InsidersTradesSigma
基于 5 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Stertzer Simon H. Director active across 1 company, notably BioCardia, Inc.. In total, 9 disclosures have been logged. Split: 7 buys · 0 sell. Total volume traded: €779k. History available since 16 December 2022. The latest transaction was disclosed on 19 September 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
STERTZER SIMON H is a Director of BioCardia, Inc. (XNAS). He has 9 filings in total, and in the sampled recent filings the buy volume is EUR 778731 and the sell volume is EUR 0, over the period from 2022-12-19 to 2026-06-24, with the modal transaction nature listed as Acquisition.